DE122012000017I1 - Neuartige form von s-omeprazol. - Google Patents
Neuartige form von s-omeprazol.Info
- Publication number
- DE122012000017I1 DE122012000017I1 DE201212000017 DE122012000017C DE122012000017I1 DE 122012000017 I1 DE122012000017 I1 DE 122012000017I1 DE 201212000017 DE201212000017 DE 201212000017 DE 122012000017 C DE122012000017 C DE 122012000017C DE 122012000017 I1 DE122012000017 I1 DE 122012000017I1
- Authority
- DE
- Germany
- Prior art keywords
- omeprazole
- novel form
- novel
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9702065A SE510650C2 (sv) | 1997-05-30 | 1997-05-30 | Ny förening |
PCT/SE1998/000974 WO1998054171A1 (en) | 1997-05-30 | 1998-05-25 | Novel form of s-omeprazole |
Publications (1)
Publication Number | Publication Date |
---|---|
DE122012000017I1 true DE122012000017I1 (de) | 2012-08-16 |
Family
ID=20407186
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69814069.9T Expired - Lifetime DE69814069T3 (de) | 1997-05-30 | 1998-05-25 | Neuartige form von s-omeprazol |
DE69829511T Expired - Lifetime DE69829511T2 (de) | 1997-05-30 | 1998-05-25 | Neuer Prozess zur Herstellung von S-Omeprazol-Magnesiumsalz-Trihydrat |
DE201212000017 Pending DE122012000017I1 (de) | 1997-05-30 | 2012-03-26 | Neuartige form von s-omeprazol. |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69814069.9T Expired - Lifetime DE69814069T3 (de) | 1997-05-30 | 1998-05-25 | Neuartige form von s-omeprazol |
DE69829511T Expired - Lifetime DE69829511T2 (de) | 1997-05-30 | 1998-05-25 | Neuer Prozess zur Herstellung von S-Omeprazol-Magnesiumsalz-Trihydrat |
Country Status (44)
Families Citing this family (110)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6875872B1 (en) * | 1993-05-28 | 2005-04-05 | Astrazeneca | Compounds |
SE9301830D0 (sv) * | 1993-05-28 | 1993-05-28 | Ab Astra | New compounds |
US5840737A (en) | 1996-01-04 | 1998-11-24 | The Curators Of The University Of Missouri | Omeprazole solution and method for using same |
ATE355375T1 (de) | 1996-01-04 | 2006-03-15 | Novartis Vaccines & Diagnostic | Bakterioferritin aus helicobacter pylori |
US6489346B1 (en) * | 1996-01-04 | 2002-12-03 | The Curators Of The University Of Missouri | Substituted benzimidazole dosage forms and method of using same |
US6645988B2 (en) * | 1996-01-04 | 2003-11-11 | Curators Of The University Of Missouri | Substituted benzimidazole dosage forms and method of using same |
US6699885B2 (en) * | 1996-01-04 | 2004-03-02 | The Curators Of The University Of Missouri | Substituted benzimidazole dosage forms and methods of using same |
SE510650C2 (sv) * | 1997-05-30 | 1999-06-14 | Astra Ab | Ny förening |
SE9900274D0 (sv) * | 1999-01-28 | 1999-01-28 | Astra Ab | New compound |
US6369087B1 (en) * | 1999-08-26 | 2002-04-09 | Robert R. Whittle | Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same |
US6316020B1 (en) | 1999-08-26 | 2001-11-13 | Robert R. Whittle | Pharmaceutical formulations |
US8206741B2 (en) | 2001-06-01 | 2012-06-26 | Pozen Inc. | Pharmaceutical compositions for the coordinated delivery of NSAIDs |
DK1487818T3 (da) * | 2002-03-05 | 2007-08-20 | Astrazeneca Ab | Alkylammoniumsalte af omeprazol og esomeprazol |
WO2003089408A2 (en) * | 2002-04-22 | 2003-10-30 | Sun Pharmaceutical Industries Limited | Optically active substituted pyridinylmethyl-sulphinyl-benzimidazole and salts |
EP1515963B1 (de) | 2002-06-27 | 2007-02-14 | Dr. Reddy's Laboratories Ltd. | Verfahren zur herstellung optisch reiner oder optisch angereicherter sulfoxidverbindungen einschliesslich amorphen esomeprazols und dessen salze |
CN100378093C (zh) * | 2002-06-27 | 2008-04-02 | 雷迪实验室有限公司 | 一种制备包括无定形艾美拉唑及其盐在内的光学纯或光学浓缩的亚砜化合物的方法 |
TW200410955A (en) | 2002-07-29 | 2004-07-01 | Altana Pharma Ag | Novel salt of (S)-PANTOPRAZOLE |
AU2003262992A1 (en) * | 2002-08-30 | 2004-03-19 | Reddy's Laboratories Limited | Amorphous hydrates of esomeprazole magnesium and process for the preparation thereof |
US8697094B2 (en) * | 2002-10-16 | 2014-04-15 | Takeda Pharmaceutical Company Limited | Stable solid preparations |
BR0315574A (pt) * | 2002-10-22 | 2005-09-20 | Ranbaxy Lab Ltd | Forma amorfa de esomeprazol, composição farmacêutica contendo o mesmo e processo para sua preparação |
US20040242642A1 (en) * | 2002-11-18 | 2004-12-02 | Dr. Reddy's Laboratories Limited | Crystalline esomeprazole compounds and process for the preparation thereof |
WO2004060263A2 (en) * | 2003-01-07 | 2004-07-22 | Ranbaxy Laboratories Limited | Magnesium salt of imidazole derivative |
WO2004089935A1 (en) * | 2003-04-10 | 2004-10-21 | Hetero Drugs Limitd | Novel crystalline forms of s-omeprazole magnesium |
WO2004099181A1 (en) | 2003-05-05 | 2004-11-18 | Ranbaxy Laboratories Limited | Barium salt of benzimidazole derivative |
US8993599B2 (en) | 2003-07-18 | 2015-03-31 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
WO2005011692A1 (en) * | 2003-07-23 | 2005-02-10 | Altana Pharma Ag | Alkaline salts of proton pump inhibitors |
CN100457104C (zh) * | 2003-07-23 | 2009-02-04 | 尼科梅德有限责任公司 | 质子泵抑制剂的碱性盐 |
SE0302382D0 (sv) | 2003-09-04 | 2003-09-04 | Astrazeneca Ab | New salts II |
SE0302381D0 (sv) | 2003-09-04 | 2003-09-04 | Astrazeneca Ab | New salts I |
US20050075371A1 (en) * | 2003-10-03 | 2005-04-07 | Allergan, Inc. | Methods and compositions for the oral administration of prodrugs of proton pump inhibitors |
US20070292498A1 (en) * | 2003-11-05 | 2007-12-20 | Warren Hall | Combinations of proton pump inhibitors, sleep aids, buffers and pain relievers |
AU2005216862A1 (en) * | 2004-02-18 | 2005-09-09 | Allergan, Inc. | Compositions comprising prodrugs of proton pump inhibitors |
US20070161679A1 (en) * | 2004-02-18 | 2007-07-12 | Allergan, Inc. | Method and compositions for the intravenous administration of compounds related to proton pump inhibitors |
MXPA06011820A (es) * | 2004-04-16 | 2006-12-15 | Santarus Inc | Combinacion de inhibidor de bomba de proton, agente regulador del ph y agente procinetico. |
US8906940B2 (en) | 2004-05-25 | 2014-12-09 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
US20050267159A1 (en) * | 2004-05-28 | 2005-12-01 | Aaipharma, Inc. | Magnesium complexes of S-omeprazole |
US20050267157A1 (en) * | 2004-05-28 | 2005-12-01 | David White | Magnesium-S-omeprazole |
JP5563735B2 (ja) | 2004-06-16 | 2014-07-30 | タケダ ファーマシューティカルズ ユー.エス.エー. インコーポレイティド | Ppi多回剤形 |
EP1765806A1 (de) * | 2004-06-24 | 2007-03-28 | AstraZeneca AB | Neues verfahren zur herstellung von kristallmodifikationen zur verwendung bei der herstellung von esomeprazol-natriumsalz |
ES2246149B1 (es) | 2004-07-02 | 2007-06-01 | Esteve Quimica, S.A. | Formas solidas de la sal magnesica de s-omeprazol y procedimientos para su preparacion. |
US20060024362A1 (en) * | 2004-07-29 | 2006-02-02 | Pawan Seth | Composition comprising a benzimidazole and process for its manufacture |
US20060160783A1 (en) * | 2004-12-30 | 2006-07-20 | Transform Pharmaceuticals, Inc. | Novel omeprazole forms and related methods |
ES2259269B1 (es) | 2005-03-03 | 2007-11-01 | Esteve Quimica, S.A. | Procedimiento para la preparacion de derivados de 2-(2-piridilmetilsulfinil)-bencimidazol opticamente activos. |
US20060210637A1 (en) * | 2005-03-17 | 2006-09-21 | Qpharma, Llc | Stable tablet dosage forms of proton pump inhibitors |
KR20080007508A (ko) * | 2005-05-06 | 2008-01-21 | 그렌마크 파머수티칼스 엘티디. | 에소메프라졸 스트론튬염, 그것의 제조방법 및 그것을함유하는 약제학적 조성물 |
WO2006134605A1 (en) | 2005-06-15 | 2006-12-21 | Hetero Drugs Limited | Amorphous esomeprazole hydrate |
EP1904064A4 (de) * | 2005-07-07 | 2009-12-02 | Reddys Lab Ltd Dr | Omeprazol form b |
US20070026071A1 (en) * | 2005-07-28 | 2007-02-01 | Qpharma, Llc | Magnesium salt proton pump inhibitor dosage forms |
KR100641534B1 (ko) | 2005-07-28 | 2006-11-01 | 한미약품 주식회사 | 에스오메프라졸 및 그의 염의 제조방법 |
WO2007031845A2 (en) * | 2005-09-14 | 2007-03-22 | Glenmark Pharmaceuticals Limited | Polymorphic forms of (s)-omeprazole magnesium salts and processes for their preparation |
AU2006299424A1 (en) * | 2005-10-06 | 2007-04-12 | Auspex Pharmaceuticals, Inc. | Deuterated inhibitors of gastric H+, K+-ATPase with enhanced therapeutic properties |
US7576219B2 (en) * | 2005-10-26 | 2009-08-18 | Hanmi Pharm. Co., Ltd | Crystalline S-omeprazole strontium hydrate, method for preparing same, and pharmaceutical composition containing same |
JP5017274B2 (ja) * | 2005-10-26 | 2012-09-05 | ハンミ・サイエンス・カンパニー・リミテッド | S−オメプラゾールストロンチウム塩またはその水和物、その製造方法、及びこれを含む医薬組成物 |
EP1801110A1 (de) | 2005-12-22 | 2007-06-27 | KRKA, tovarna zdravil, d.d., Novo mesto | Argininsalz des Esomeprazols |
US7553857B2 (en) * | 2005-12-23 | 2009-06-30 | Lek Pharmaceuticals D.D. | S-omeprazole magnesium |
CN100384839C (zh) * | 2006-02-17 | 2008-04-30 | 中国科学院上海有机化学研究所 | [(取代的吡啶基)甲基]亚磺酰基-1h-苯并咪唑类化合物及其对映体的锌盐的制备方法 |
US7579476B2 (en) * | 2006-02-24 | 2009-08-25 | Praktikatalyst Pharma, Llc | Transition metal mediated oxidation of hetero atoms in organic molecules coordinated to transition metals |
US8063074B2 (en) | 2006-05-04 | 2011-11-22 | Dr. Reddy's Laboratories Limited | Polymorphic forms of esomeprazole sodium |
EP2040710A2 (de) * | 2006-06-21 | 2009-04-01 | Glenmark Pharmaceuticals Limited | Neuer polymorph von esomeprazol-kalium und verfahren zu seiner herstellung |
WO2008067037A2 (en) | 2006-10-05 | 2008-06-05 | Santarus, Inc. | Novel formulations of proton pump inhibitors and methods of using these formulations |
US20080103169A1 (en) | 2006-10-27 | 2008-05-01 | The Curators Of The University Of Missouri | Compositions comprising acid labile proton pump inhibiting agents, at least one other pharmaceutically active agent and methods of using same |
EP1947099A1 (de) | 2007-01-18 | 2008-07-23 | LEK Pharmaceuticals D.D. | Verfahren zur Entfernung von Lösungsmitteln in Omeprazol-Salzen |
EP2114919A2 (de) | 2007-01-31 | 2009-11-11 | Krka Tovarna Zdravil, D.D., Novo Mesto | Verfahren zur herstellung von optisch reinem omeprazol durch salzbildung mit einem chiralen amin oder behandlung mit einem enantiomer umwandelnden enzym und chromatographische auftrennung |
AU2008217603C1 (en) * | 2007-02-21 | 2013-08-15 | Cipla Limited | Process for the preparation of esomeprazole magnesium dihydrate |
KR101303813B1 (ko) * | 2007-04-16 | 2013-09-04 | 에스케이케미칼주식회사 | 라세믹 오메프라졸로부터 에스오메프라졸의 개선된제조방법 |
EP2000468A1 (de) | 2007-05-09 | 2008-12-10 | Dr. Reddy's Laboratories Ltd. | Esomeprazolsalze und Verfahren zur Herstellung davon |
EP2152691B1 (de) * | 2007-06-07 | 2011-11-23 | Aurobindo Pharma Limited | Verbessertes verfahren zur herstellung eines optisch aktiven protonenpumpenhemmers |
FR2920428B1 (fr) * | 2007-08-29 | 2012-06-15 | Univ Rouen | Procede de dedoublement de sels de l'omeprazole |
US8106210B2 (en) * | 2007-10-08 | 2012-01-31 | Hetero Drugs Limited | Polymorphs of esomeprazole salts |
KR20170097787A (ko) | 2007-10-12 | 2017-08-28 | 다케다 파마슈티칼스 유에스에이, 인코포레이티드 | 음식 섭취와 관계없이 위장 장애를 치료하는 방법 |
WO2009074997A2 (en) * | 2007-12-10 | 2009-06-18 | Lee Pharma Ltd. | A novel process for the preparation of crystalline magnesium salt of (s)-omeprazole di hydrate |
WO2009099933A2 (en) * | 2008-02-01 | 2009-08-13 | Dr. Reddy's Laboratories Ltd. | Preparation of esomeprazole magnesium and hydrates thereof |
US20090280173A1 (en) * | 2008-05-09 | 2009-11-12 | Ishwar Chauhan | Multilayer Omeprazole Tablets |
US20090280175A1 (en) * | 2008-05-09 | 2009-11-12 | Ishwar Chauhan | Multilayer Proton Pump Inhibitor Tablets |
EP2143722A1 (de) | 2008-07-09 | 2010-01-13 | Lek Pharmaceuticals D.D. | Verfahren zur Herstellung von Esomeprazol-Natrium von hoher chemischer Reinheit und neue Formen von Esomeprazol-Natrium |
EP2147918A1 (de) * | 2008-07-21 | 2010-01-27 | LEK Pharmaceuticals D.D. | Verfahren zur Herstellung von S-Omeprazol-Magnesium in einer stabilen Form |
MX2011002515A (es) | 2008-09-09 | 2011-04-07 | Astrazeneca Ab | Metodo de administracion de una composicion farmaceutica a un paciente que lo necesita. |
CN101391993B (zh) * | 2008-10-28 | 2012-07-04 | 安徽美诺华药物化学有限公司 | 通过与(s)-(-)-1,1'-联萘-2,2'-二酚形成包合配合物制备s-奥美拉唑及其盐的方法 |
WO2010097583A1 (en) | 2009-02-24 | 2010-09-02 | Cipla Limited | Esomeprazole potassium polymorph and its preparation |
US20100267959A1 (en) * | 2009-04-15 | 2010-10-21 | Glenmark Generics Limited | Process for the preparation of esomeprazole magnesium dihydrate |
WO2010122583A2 (en) | 2009-04-24 | 2010-10-28 | Rubicon Research Private Limited | Oral pharmaceutical compositions of acid labile substances |
US20130030186A1 (en) * | 2009-06-02 | 2013-01-31 | Sun Pharmaceutical Industries Limited | Process for preparing sulphoxide compounds |
MX2011013467A (es) | 2009-06-25 | 2012-02-13 | Astrazeneca Ab | Metodo para tratar un paciente que corre el riesgo de desarollar una ulcera asociada a antiinflamatorio no esteroide (aine). |
US20110008432A1 (en) * | 2009-06-25 | 2011-01-13 | Pozen Inc. | Method for Treating a Patient in Need of Aspirin Therapy |
WO2011012957A1 (en) * | 2009-07-29 | 2011-02-03 | Orchid Chemicals & Pharmaceuticals Ltd | An improved process for the preparation of esomeprazole magnesium dihydrate |
US8748619B2 (en) | 2009-11-12 | 2014-06-10 | Hetero Research Foundation | Process for the resolution of omeprazole |
EP2510089B1 (de) | 2009-12-08 | 2015-10-21 | Codexis, Inc. | Synthese von prazolverbindungen |
US20110207779A1 (en) * | 2010-02-25 | 2011-08-25 | Glenmark Generics Ltd | Process for the preparation of esomeprazole magnesium |
FR2959509B1 (fr) | 2010-05-03 | 2012-07-13 | Prod Chim Auxiliaires Et De Synthese | Phase precurseur et son utilisation pour preparer le sel de magnesium tetrahydrate d'un enantiomere d'omeprazole |
CN102241668B (zh) * | 2010-05-11 | 2015-11-25 | 中国科学院成都有机化学有限公司 | S-奥美拉唑盐 |
EP2649187B1 (de) | 2010-12-08 | 2017-11-22 | Codexis, Inc. | Biokatalysatoren und verfahren zur synthese von armodafinil |
CN102757421A (zh) * | 2011-04-29 | 2012-10-31 | 江苏正大天晴药业股份有限公司 | 埃索美拉唑的纯化方法 |
CN102911158B (zh) * | 2011-07-31 | 2015-07-22 | 连云港润众制药有限公司 | 埃索美拉唑镁的晶型 |
CN102924435B (zh) * | 2011-11-25 | 2014-06-25 | 成都自豪药业有限公司 | S-奥美拉唑镁盐的晶型及其制备方法 |
WO2013088272A1 (en) * | 2011-12-14 | 2013-06-20 | Wockhardt Limited | Pharmaceutical composition comprising esomeprazole magnesium dihydrate |
MX2014007935A (es) | 2011-12-28 | 2014-11-14 | Pozen Inc | Composiciones y metodos mejorados para el suministro de omeprazol y de acido acetilsalicilico. |
CN102584792B (zh) * | 2012-01-06 | 2014-06-11 | 南京优科生物医药研究有限公司 | 制备高纯度的埃索美拉唑盐的方法 |
CN102993184A (zh) * | 2013-01-08 | 2013-03-27 | 湖南方盛制药股份有限公司 | 一种埃索美拉唑及其镁盐三水合物的制备方法 |
CN104250243B (zh) * | 2013-06-27 | 2016-12-28 | 四川国为制药有限公司 | 一种埃索美拉唑镁二水合物a晶型的制备方法 |
CN103570686B (zh) * | 2013-10-14 | 2015-04-01 | 哈药集团技术中心 | 一种埃索美拉唑钠的合成及精制工艺 |
CN104725357A (zh) * | 2013-12-24 | 2015-06-24 | 苏州联友制药技术有限公司 | 一种埃索美拉唑镁二水合物晶型b的制备方法 |
FR3018812A1 (fr) * | 2014-03-21 | 2015-09-25 | Minakem | Nouvelle phase intermediaire de la forme a du sel de magnesium dihydrate d'un enantiomere de l'omeprazole |
CN104447699A (zh) * | 2014-12-10 | 2015-03-25 | 哈药集团技术中心 | 一种埃索美拉唑镁三水合物的制备方法 |
CN105111188B (zh) * | 2015-08-19 | 2018-01-19 | 扬子江药业集团有限公司 | 一种埃索美拉唑镁三水合物晶型的制备方法 |
WO2017145146A1 (en) | 2016-02-25 | 2017-08-31 | Dexcel Pharma Technologies Ltd. | Compositions comprising proton pump inhibitors |
CN106397402B (zh) * | 2016-08-30 | 2019-05-03 | 山东罗欣药业集团股份有限公司 | 一种埃索美拉唑镁晶型化合物及其制备方法 |
KR102080023B1 (ko) | 2018-01-29 | 2020-02-21 | 주식회사 종근당 | 에스오메프라졸 및 탄산수소나트륨을 포함하는 안정한 약제학적 조성물 |
KR102006777B1 (ko) | 2018-01-29 | 2019-10-08 | 주식회사 종근당 | 에스오메프라졸 및 탄산수소나트륨을 포함하는 약제학적 제제 |
KR102432084B1 (ko) | 2021-11-16 | 2022-08-12 | 알리코제약(주) | S-오메프라졸을 함유하는 안정성이 개선되고 소형화된 정제 |
WO2024075017A1 (en) | 2022-10-04 | 2024-04-11 | Zabirnyk Arsenii | Inhibition of aortic valve calcification |
Family Cites Families (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE7804231L (sv) | 1978-04-14 | 1979-10-15 | Haessle Ab | Magsyrasekretionsmedel |
SE8301182D0 (sv) * | 1983-03-04 | 1983-03-04 | Haessle Ab | Novel compounds |
US5244891A (en) * | 1985-08-05 | 1993-09-14 | Bristol-Myers Squibb Company | Injectable compositions of cefepime dihydrochloride hydrate |
GB2189698A (en) | 1986-04-30 | 1987-11-04 | Haessle Ab | Coated omeprazole tablets |
US5204118A (en) | 1989-11-02 | 1993-04-20 | Mcneil-Ppc, Inc. | Pharmaceutical compositions and methods for treating the symptoms of overindulgence |
DE4035455A1 (de) | 1990-11-08 | 1992-05-14 | Byk Gulden Lomberg Chem Fab | Enantiomerentrennung |
US5360582A (en) | 1991-07-15 | 1994-11-01 | Minnesota Mining And Manufacturing Company | Nonlinear optical materials containing polar disulfone-functionalized molecules |
SE9301830D0 (sv) * | 1993-05-28 | 1993-05-28 | Ab Astra | New compounds |
US5877192A (en) | 1993-05-28 | 1999-03-02 | Astra Aktiebolag | Method for the treatment of gastric acid-related diseases and production of medication using (-) enantiomer of omeprazole |
SE9302395D0 (sv) * | 1993-07-09 | 1993-07-09 | Ab Astra | New pharmaceutical formulation |
SE9302396D0 (sv) * | 1993-07-09 | 1993-07-09 | Ab Astra | A novel compound form |
FR2719045B1 (fr) * | 1994-04-20 | 1996-05-31 | Rhone Poulenc Chimie | Procédé de préparation d'acide L-aspartique à partir d'aspartate d'ammonium. |
DK0723436T3 (da) | 1994-07-08 | 2001-11-26 | Astrazeneca Ab | Tabletteret flerenhedsdoseringsform |
FR2722191B1 (fr) * | 1994-07-08 | 1996-08-23 | Rhone Poulenc Rorer Sa | Procede de preparation du trihydrate du (2r,3s)-3-tertbutoxycarbonylamino-2-hydroxy-3-phenylpropionate de 4-acetoxy2alpha-benzoyloxy-5beta,20epoxy-1,7beta,10beta trihydroxy-9-oxo-tax-11-en-13alpha-yle |
SE504459C2 (sv) | 1994-07-15 | 1997-02-17 | Astra Ab | Förfarande för framställning av substituerade sulfoxider |
EP0792879B1 (de) * | 1994-11-14 | 2001-02-28 | Daiichi Pharmaceutical Co., Ltd. | Verfahren zur Herstellung von 3-[2-[4-(3-Chlor-2-methylphenyl)-1- piperazinyl] ethyl]-5,6-dimethoxy-1-(4-imidazolylmethyl)-1H-indazol-dihydrochlorid-3.5-hydrat. |
GB9423970D0 (en) * | 1994-11-28 | 1995-01-11 | Astra Ab | Oxidation |
SE9500422D0 (sv) | 1995-02-06 | 1995-02-06 | Astra Ab | New oral pharmaceutical dosage forms |
CN1042423C (zh) | 1995-05-25 | 1999-03-10 | 常州市第四制药厂 | 奥美拉唑盐水合物及其制备方法 |
SE9600070D0 (sv) | 1996-01-08 | 1996-01-08 | Astra Ab | New oral pharmaceutical dosage forms |
SE9600072D0 (sv) | 1996-01-08 | 1996-01-08 | Astra Ab | New oral formulation of two active ingredients II |
SE9600071D0 (sv) | 1996-01-08 | 1996-01-08 | Astra Ab | New oral formulation of two active ingredients I |
SE510650C2 (sv) | 1997-05-30 | 1999-06-14 | Astra Ab | Ny förening |
US6747155B2 (en) | 1997-05-30 | 2004-06-08 | Astrazeneca Ab | Process |
AR057181A1 (es) | 2005-11-30 | 2007-11-21 | Astra Ab | Nueva forma de dosificacion de combinacion |
-
1997
- 1997-05-30 SE SE9702065A patent/SE510650C2/sv not_active IP Right Cessation
-
1998
- 1998-05-05 US US09/077,719 patent/US6369085B1/en not_active Expired - Lifetime
- 1998-05-15 HR HR980263A patent/HRP980263B1/xx not_active IP Right Cessation
- 1998-05-18 ZA ZA984179A patent/ZA984179B/xx unknown
- 1998-05-18 AR ARP980102299A patent/AR012717A1/es active IP Right Grant
- 1998-05-18 TW TW087107675A patent/TW538040B/zh not_active IP Right Cessation
- 1998-05-18 DZ DZ980105A patent/DZ2495A1/xx active
- 1998-05-21 MA MA25085A patent/MA26500A1/fr unknown
- 1998-05-25 EP EP98926005.4A patent/EP0984957B3/de not_active Expired - Lifetime
- 1998-05-25 AT AT02019642T patent/ATE291574T1/de active
- 1998-05-25 SI SI9830424T patent/SI0984957T1/xx unknown
- 1998-05-25 JP JP50057899A patent/JP4002303B2/ja not_active Expired - Lifetime
- 1998-05-25 TR TR1999/02934T patent/TR199902934T2/xx unknown
- 1998-05-25 CA CA002521391A patent/CA2521391C/en not_active Expired - Lifetime
- 1998-05-25 AT AT98926005T patent/ATE239011T1/de active
- 1998-05-25 WO PCT/SE1998/000974 patent/WO1998054171A1/en active Application Filing
- 1998-05-25 SK SK76-2005A patent/SK285137B6/sk not_active IP Right Cessation
- 1998-05-25 RS RSP-2007/0459A patent/RS50067B/sr unknown
- 1998-05-25 CZ CZ20041090A patent/CZ297585B6/cs not_active IP Right Cessation
- 1998-05-25 NZ NZ500991A patent/NZ500991A/en not_active IP Right Cessation
- 1998-05-25 EE EEP199900550A patent/EE03875B1/xx active Protection Beyond IP Right Term
- 1998-05-25 ES ES98926005.4T patent/ES2195345T7/es active Active
- 1998-05-25 PL PL98337180A patent/PL193546B1/pl unknown
- 1998-05-25 DK DK02019642T patent/DK1273581T3/da active
- 1998-05-25 ES ES02019642T patent/ES2236407T3/es not_active Expired - Lifetime
- 1998-05-25 RS YUP-609/99A patent/RS50005B/sr unknown
- 1998-05-25 DK DK98926005T patent/DK0984957T3/da active
- 1998-05-25 IL IL13294798A patent/IL132947A0/xx not_active IP Right Cessation
- 1998-05-25 PT PT02019642T patent/PT1273581E/pt unknown
- 1998-05-25 ME MEP-249/08A patent/MEP24908A/xx unknown
- 1998-05-25 DE DE69814069.9T patent/DE69814069T3/de not_active Expired - Lifetime
- 1998-05-25 RU RU99128072/04A patent/RU2184115C2/ru active Protection Beyond IP Right Term
- 1998-05-25 SI SI9830761T patent/SI1273581T1/xx unknown
- 1998-05-25 PT PT98926005T patent/PT984957E/pt unknown
- 1998-05-25 DE DE69829511T patent/DE69829511T2/de not_active Expired - Lifetime
- 1998-05-25 KR KR10-2005-7006896A patent/KR100527804B1/ko not_active IP Right Cessation
- 1998-05-25 CN CNB98805521XA patent/CN1161351C/zh not_active Expired - Lifetime
- 1998-05-25 UA UA99116288A patent/UA60334C2/uk unknown
- 1998-05-25 CA CA002290963A patent/CA2290963C/en not_active Expired - Lifetime
- 1998-05-25 ME MEP-2008-249A patent/ME00198B/me unknown
- 1998-05-25 HU HU0001849A patent/HU225987B1/hu active Protection Beyond IP Right Term
- 1998-05-25 EP EP02019642A patent/EP1273581B1/de not_active Expired - Lifetime
- 1998-05-25 ID IDW991449A patent/ID29306A/id unknown
- 1998-05-25 BR BR9809509-9A patent/BR9809509A/pt not_active Application Discontinuation
- 1998-05-25 KR KR1019997011106A patent/KR100540720B1/ko not_active IP Right Cessation
- 1998-05-25 SK SK1625-99A patent/SK284837B6/sk not_active IP Right Cessation
- 1998-05-25 ME MEP-180/08A patent/MEP18008A/xx unknown
- 1998-05-25 AU AU77935/98A patent/AU722839B2/en not_active Expired
- 1998-05-27 EG EG58098A patent/EG24291A/xx active
- 1998-05-29 MY MYPI20032997A patent/MY127793A/en unknown
- 1998-05-29 MY MYPI98002399A patent/MY120745A/en unknown
- 1998-05-29 TN TNTNSN98074A patent/TNSN98074A1/fr unknown
- 1998-07-12 SA SA5260296A patent/SA05260296B1/ar unknown
- 1998-07-12 SA SA98190280A patent/SA98190280B1/ar unknown
-
1999
- 1999-11-25 IS IS5272A patent/IS2142B/is unknown
- 1999-11-29 NO NO19995852A patent/NO317518B1/no not_active IP Right Cessation
-
2000
- 2000-08-17 HK HK03103300A patent/HK1051681A1/xx not_active IP Right Cessation
- 2000-08-17 HK HK00105176A patent/HK1025962A1/xx not_active IP Right Cessation
-
2002
- 2002-02-14 US US10/076,711 patent/US6677455B2/en not_active Expired - Lifetime
-
2003
- 2003-09-25 US US10/672,936 patent/US7411070B2/en not_active Expired - Fee Related
-
2006
- 2006-03-22 IS IS8368A patent/IS2774B/is unknown
-
2007
- 2007-02-20 AR ARP070100714A patent/AR059589A2/es active IP Right Grant
- 2007-03-16 JP JP2007068061A patent/JP2007161734A/ja active Pending
- 2007-09-11 US US11/853,323 patent/US7745466B2/en not_active Expired - Fee Related
-
2010
- 2010-05-21 US US12/784,881 patent/US8076361B2/en not_active Expired - Fee Related
-
2011
- 2011-06-07 NO NO2011010C patent/NO2011010I1/no not_active Application Discontinuation
- 2011-09-19 LU LU91871C patent/LU91871I2/fr unknown
- 2011-11-17 US US13/298,373 patent/US8466175B2/en not_active Expired - Fee Related
-
2012
- 2012-03-26 DE DE201212000017 patent/DE122012000017I1/de active Pending
- 2012-06-05 NO NO2012011C patent/NO2012011I1/no unknown
- 2012-06-06 LU LU92017C patent/LU92017I2/fr unknown
- 2012-11-05 CY CY2012029C patent/CY2012029I1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE122012000017I1 (de) | Neuartige form von s-omeprazol. | |
DE69928195D1 (de) | Komplettierung von Untrerdruck-Bohrlöchern | |
DE69837906D1 (de) | Insektizides proteintoxin von xenorhabus | |
MX209959B (es) | 4-(3-heterociclil-1-benzoil)pirazoles | |
MX212055B (es) | Microemulsion. | |
EE03903B1 (et) | Omeprasooli ravimvorm | |
DE19882124T1 (de) | Direkte Abscheidung von Gold | |
DE60008353D1 (de) | Hemihydrat von 16.alpha.-bromoepiandrosterone | |
PT964867E (pt) | Antagonistas da taquicinima | |
MA24551A1 (fr) | W.c. | |
NO20002555L (no) | Skjøt | |
ES1036909Y (es) | Pupitre infantil. | |
FI972138A0 (fi) | Returtraog i bestrykningsanordning | |
ES1037395Y (es) | Tendedero antilluvia. | |
FI972885A0 (fi) | Anordning foer utfoering av en divisionoperation, saerskilt i en tredimensionell grafik | |
DE29710141U1 (de) | Aufhängevorrichtung von Schürzen | |
ITPR970022V0 (it) | Profilorete asimmetrico. | |
ES1036948Y (es) | Carpeta-atril mejorada. | |
ES1038416Y (es) | Gregadero mejorado. | |
ES1036324Y (es) | Cose-papeles mejorado. | |
KR970021293U (ko) | 특허 출원서 행정 양식 | |
DE29720614U1 (de) | Begrenzungen von Ställen | |
ES1036787Y (es) | Carterita-neceser. | |
ES1037763Y (es) | Iluminaria. | |
ES1038270Y (es) | Anillo-grafo. |